Document is current

Any future updates will be listed below

Correction: Targeting the DIO3 enzyme using first-in-class inhibitors effectively suppresses tumor growth: a new paradigm in ovarian cancer treatment

Crossref DOI link: https://doi.org/10.1038/s41388-023-02629-2

Published Online: 2023-03-15

Published Print: 2023-05-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark